On Tuesday, Needham reaffirmed its Buy rating on shares of Glaukos Corporation (NYSE:) with a steady price target of $149.00.…
Read More »maintains
Citi has reiterated its Neutral stance on DNB ASA (OTC:) (DNB: NO) (OTC: DNHBY), maintaining a price target of NOK212.00.…
Read More » Citi has updated its outlook on Western Alliance (NYSE:) Bancorporation (NYSE: WAL), raising the price target from $98.00 to $102.00,…
Read More »On Thursday, Oppenheimer maintained its Outperform rating and $25.00 stock price target for Immuneering Corporation (NASDAQ:IMRX). Following a discussion with…
Read More »On Monday, TD Cowen reaffirmed its Buy rating on shares of Humacyte (NASDAQ:HUMA) with a consistent price target of $10.00.…
Read More »Needham has maintained a Buy rating and a $260.00 price target on Apple Inc. (NASDAQ: NASDAQ:) shares. The firm’s outlook…
Read More »Oppenheimer has maintained its positive stance on Immunovant (NASDAQ: NASDAQ:), reaffirming an Outperform rating and a $47.00 price target on…
Read More »On Friday, Needham & Company maintained their Buy rating on shares of Workday, Inc. (NASDAQ:), with a consistent price target…
Read More »Tuesday, August 13, 2024 – UroGen Pharma (NASDAQ:URGN) has maintained its Buy rating according to recent comments from TD Cowen.…
Read More »On Monday, Citi revised its stock price target for Macy’s (NYSE:), lowering it to $17.00 from the previous $22.00, while…
Read More »